CVRx (CVRX) EBITDA (2020 - 2026)
CVRx's (CVRX) quarterly EBITDA came in at -$12.2 million in Q1 2026, up 9.5% year-on-year from -$11.1 million in Q1 2025, and down 8.74% quarter-over-quarter from -$11.2 million in Q4 2025.
CVRx (CVRX) EBITDA (2020 - 2026) Analysis & Trends
CVRx's EBITDA history runs 7 years deep, the most recent figure standing at -$12.2 million for Q1 2026.
- On a quarterly basis, EBITDA rose 9.5% year-over-year to -$12.2 million in Q1 2026; TTM through Mar 2026 was -$50.0 million, a 1.39% increase from a year earlier, with the FY2025 full-year figure at -$51.3 million, up 13.83% from the prior year.
- EBITDA declined to -$12.2 million in Q1 2026 per CVRX's latest filing, from -$11.2 million in the prior quarter.
- Across five years, EBITDA topped out at -$9.5 million in Q3 2023 and bottomed at -$22.2 million in Q1 2024.
- The 5-year median for EBITDA is -$11.8 million (2023), against an average of -$12.3 million.
- Across the five-year window, EBITDA slumped 134.95% in 2022 and soared 39.56% in 2025, its largest moves.
- Year by year, EBITDA stood at -$11.5 million in 2022, then increased by 15.84% to -$9.7 million in 2023, then fell by 6.35% to -$10.3 million in 2024, then retreated by 8.86% to -$11.2 million in 2025, then fell by 8.74% to -$12.2 million in 2026.
- Per Business Quant, the three latest CVRX EBITDA figures stand at -$12.2 million (Q1 2026), -$11.2 million (Q4 2025), and -$12.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.16 Mn |
| Dec 31, 2025 | -11.18 Mn |
| Sep 30, 2025 | -12.27 Mn |
| Jun 30, 2025 | -14.38 Mn |
| Mar 31, 2025 | -13.44 Mn |
| Dec 31, 2024 | -10.27 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Jun 30, 2024 | -13.97 Mn |
| Mar 31, 2024 | -22.23 Mn |
| Dec 31, 2023 | -9.66 Mn |
| Sep 30, 2023 | -9.53 Mn |
| Jun 30, 2023 | -11.75 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -11.48 Mn |
| Sep 30, 2022 | -10.13 Mn |
| Jun 30, 2022 | -11.01 Mn |
| Mar 31, 2022 | -9.91 Mn |
| Dec 31, 2021 | -8.79 Mn |
| Sep 30, 2021 | -7.29 Mn |
| Jun 30, 2021 | -5.67 Mn |